Jump to content
Advertisement

Advertisement

IBS News

Showing topics posted by Health Reporter and posted in for the last 365 days.

This stream auto-updates

  1. Yesterday
  2. Efficacy of a curcumin extract (Curcugen™) on gastrointestinal symptoms and intestinal microbiota in adults with self-reported digestive complaints: a randomised, double-blind, placebo-controlled study. BMC Complement Med Ther. 2021 Jan 21;21(1):40 Authors: Lopresti AL, Smith SJ, Rea A, Michel S Abstract BACKGROUND: There is preliminary evidence to suggest curcumin can alleviate digestive symptoms in adults with self-reported digestive complaints and irritable bowel syndrome. However, in all these trials, curcumin was used as a component of a multi-herbal combination and there
  3. Irritable Bowel Syndrome in Pregnancy. Am J Gastroenterol. 2021 Jan 21;: Authors: Moosavi S, Pimentel M, Wong MS, Rezaie A Abstract Irritable bowel syndrome (IBS) affects a significant percentage of the general population and is more common in women. A large proportion of women affected with IBS are of childbearing age; however, there is a paucity of studies and guidelines to specifically address the epidemiology, course, maternal/fetal prognosis, or management of IBS in pregnancy. This scarcity of literature on IBS and pregnancy poses significant challenges to healthcare prov
  4. Last week
  5. An evaluation of dietary adequacy among patients with constipation-predominant irritable bowel syndrome in Malaysia. Intest Res. 2021 Jan 22;: Authors: Shafiee NH, Razalli NH, Mokhtar NM, Tan E, Ali RAR Abstract Background/Aims: Substantial proportions of patients with constipation-predominant irritable bowel syndrome (IBS-C) linked their symptoms with particular intake of foods. However, there is lack of current data regarding the intake among IBS-C patients before any dietary interventions. Thus, this study aimed to evaluate the dietary adequacy among IBS-C against the stand
  6. On the Spot: Irritable Bowel Syndrome Gastroenterology & Endoscopy News This month’s On the Spot focuses on the latest in irritable bowel syndrome, one of the thorniest conditions that gastroenterologists regularly manage. Our expert panel discusses the most up-to-date evidence for the role of probiotics in the treatment of people with IBS, the effectiveness of special diets and much more. View the full article
  7. Increased prevalence of irritable bowel syndrome in migraine patients: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2021 Jan 18;: Authors: Wongtrakul W, Charoenngam N, Ungprasert P Abstract OBJECTIVE: Even though evidence showing increased prevalence of irritable bowel syndrome (IBS) among migraine patients exists, it has not been well-established and the magnitude of association varies substantially across the studies. This study aimed to comprehensively compare the prevalence of IBS among migraineurs versus nonmigraineurs using the systematic review an
  8. Cannabis Use is Associated With Reduced 30-Day All-cause Readmission Among Hospitalized Patients With Irritable Bowel Syndrome: A Nationwide Analysis. J Clin Gastroenterol. 2021 Jan 20;: Authors: Choi C, Abougergi M, Peluso H, Weiss SH, Nasir U, Pyrsopoulos N Abstract BACKGROUND: Cannabinoid receptors are potential therapeutic targets in a variety of gastrointestinal tract disorders. The authors hypothesize that the use of cannabis use is associated with better control of symptoms associated with irritable bowel syndrome (IBS). This study aimed to examine the utilization of in
  9. Low FODMAP diet in patients with diarrhoea predominant irritable bowel syndrome: a prospective, randomised trial. J Gastroenterol Hepatol. 2021 Jan 19;: Authors: Goyal O, Batta S, Nohria S, Kishore H, Goyal P, Sehgal R, Sood A Abstract AIM: Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet improves irritable bowel syndrome (IBS) symptoms. Data on long-term 'modified' FODMAP diet is emerging. We aimed to assess efficacy and acceptability of short-term 'strict' low FODMAP diet (LFD) and long-term 'modified' FODMAP diet in patients with I
  10. Important findings showing the efficacy of diaphragmatic breathing for #GERD https://twitter.com/magnushallandmd/status/1351694167915847681 (Feed generated with FetchRSS) View the full article
  11. Earlier
  12. This will be a great intro to #lowFODMAP diet. And it's FREE! https://twitter.com/GIonDemand/status/1350158116508282887 (Feed generated with FetchRSS) View the full article
  13. Clinical, Physiological, and Psychological Correlates of the Improvement of Defecation during Menses in Women with Functional Gastrointestinal Disorders. Visc Med. 2020 Dec;36(6):487-493 Authors: Bouchoucha M, Devroede G, Rompteaux P, Mary F, Bejou B, Benamouzig R Abstract Background/Aims: Little is known about the improvement in defecation frequently reported by women around menses. We aimed to describe clinical, physiological, and psychological correlates of this improvement in those with functional bowel disorders. Patients and Methods: We recruited 478 consecutive premen
  14. A carbohydrate-restricted diet for patients with irritable bowel syndrome lowers serum C-peptide, insulin, and leptin without any correlation with symptom reduction. Nutr Res. 2020 Dec 04;86:23-36 Authors: Saidi K, Nilholm C, Roth B, Ohlsson B Abstract Alterations in gut endocrine cells and hormone levels have been measured in patients with irritable bowel syndrome (IBS). The hypothesis of the present study was that hormone levels would change after 4 weeks of a starch- and sucrose-reduced diet (SSRD) intervention corresponding to decreased carbohydrate intake and symptoms. Am
  15. Is THIS what causes IBS? Food poisoning can trigger an 'allergy' - and antihistamines can stop pain Daily Mail Mice were infected with a stomach virus and then fed them ovalbumin, a protein found in egg white that provokes an immune response The mice had types of cell called mast cells activated, which releases histamine, a compound that leads to digestive intolerance and abdominal pain Their conditions were similar to patients with irritable bowel syndrome, an intestinal disorder Researchers believe IBS may be triggered like an 'allergy' and that treating p
  16. Scientists reveal mechanism that causes irritable bowel syndrome Mirage News KU Leuven researchers have identified the biological mechanism that explains why some people experience abdominal pain when they eat certain foods. The finding paves the way for more efficient treatment of irritable bowel syndrome and other food intolerances. The study, carried out in mice and humans, was published in Nature. Up to 20% of the world’s population suffers from irritable bowel syndrome (IBS), which causes stomach pain or severe discomfort after eating. This affects their quality of life. Gluten
  17. What causes IBS pain? It may be a local immune reaction Science Magazine For the millions of people with irritable bowel syndrome (IBS), the condition’s cramping, diarrhea, and constipation are frustrating and distressing. And it’s made worse when doctors sometimes dismiss the symptoms, attributing them to anxiety or even the imagination—“all in the mind or between the ears,” says Guy Boeckxstaens, a gastroenterologist at KU Leuven. It’s an argument Boeckxstaens rejects, and for years he’s sought to understand one hallmark of IBS: abdominal pain brought on by eating. This week
  18. Does rifaximin offer any promise in Crohn's disease in remission and concurrent irritable bowel syndrome-like symptoms? Medicine (Baltimore). 2021 Jan 08;100(1):e24059 Authors: Tocia C, Dumitru IM, Alexandrescu L, Petcu LC, Dumitru E Abstract ABSTRACT: Microbiota plays an important role in many diseases including inflammatory bowel diseases. Inflammatory bowel disease patients can have concurrent irritable bowel syndrome symptoms similar to those associated with a flare. The potential role of gut dysbiosis in the pathogenesis of inflammatory bowel disease provides a rationale
  19. Altered Gut Microbiota in Irritable Bowel Syndrome and Its Association with Food Components. J Pers Med. 2021 Jan 08;11(1): Authors: Barandouzi ZA, Lee J, Maas K, Starkweather AR, Cong XS Abstract The interplay between diet and gut microbiota has gained interest as a potential contributor in pathophysiology of irritable bowel syndrome (IBS). The purpose of this study was to compare food components and gut microbiota patterns between IBS patients and healthy controls (HC) as well as to explore the associations of food components and microbiota profiles. A cross-sectional study
  20. Price Is Right: Exploring Prescription Drug Coverage Barriers for Irritable Bowel Syndrome Using Threshold Pricing Analysis. Dig Dis Sci. 2021 Jan 12;: Authors: Shah ED, Chang L, Lembo A, Staller K, Curley MA, Chey WD Abstract BACKGROUND: Prescription drug costs exert profound effects on commercial insurance coverage and access to effective therapy. AIMS: We aimed to assess threshold pricing to achieve budget neutrality of FDA-approved drugs treating irritable bowel syndrome from an insurance perspective, based on cost-savings resulting in decreased healthcare utilization th
  21. RT @DBelardoMD: Patients are the victims here. They just want health and happiness like the rest of us. Many patients are scared and they trust their healthcare providers to practice ethical and evidence based medicine. 💔 (Feed generated with FetchRSS) View the full article
  22. RedHill's Partner Cosmo Pharmaceuticals Successfully Completes Phase 2 Study of Rifamycin SV-MMX 600mg in IBS-D PRNewswire TEL AVIV, Israel and RALEIGH, N.C,, Jan. 11, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or "the Company"), a specialty biopharmaceutical company, today reported that its partner, Cosmo Pharmaceuticals (SIX: COPN) ("Cosmo"), announced that it had successfully completed their Phase 2 Proof-of-Concept (POC) clinical trial of Rifamycin SV-MMX 600mg in patients with diarrhea-predominant irritable bowel syndrome (IBS-D). As part of
  23. The fecal mycobiome in patients with Irritable Bowel Syndrome. Sci Rep. 2021 Jan 08;11(1):124 Authors: Das A, O'Herlihy E, Shanahan F, O'Toole PW, Jeffery IB Abstract Alterations of the gut microbiota have been reported in various gastrointestinal disorders, but knowledge of the mycobiome is limited. We investigated the gut mycobiome of 80 patients with Irritable Bowel Syndrome (IBS) in comparison with 64 control subjects. The fungal-specific internal transcribed spacer 1 (ITS-1) amplicon was sequenced, and mycobiome zero-radius operational taxonomic units (zOTUs) were defined
  24. A Comprehensive Self-Management Program With Diet Education Does Not Alter Microbiome Characteristics in Women With Irritable Bowel Syndrome. Biol Res Nurs. 2021 Jan 08;:1099800420984543 Authors: Kamp KJ, Plantinga AM, Cain KC, Burr RL, Barney P, Jarrett M, Luna RA, Savidge T, Shulman R, Heitkemper MM Abstract BACKGROUND AND PURPOSE: Changes in diet and lifestyle factors are frequently recommended for persons with irritable bowel syndrome (IBS). It is unknown whether these recommendations alter the gut microbiome and/or whether baseline microbiome predicts improvement in sympt
  25. The level and prevalence of depression and anxiety among patients with different subtypes of irritable bowel syndrome: a network meta-analysis. BMC Gastroenterol. 2021 Jan 07;21(1):23 Authors: Hu Z, Li M, Yao L, Wang Y, Wang E, Yuan J, Wang F, Yang K, Bian Z, Zhong LLD Abstract BACKGROUND: Irritable bowel syndrome (IBS) is a very common functional bowel disorder. However, the difference of depression and anxiety comorbidities among different IBS subtypes is still not well evaluated. This study aims to investigate the difference in the level and prevalence of depression and anx
  26. Impact of Opioid Consumption in Patients With Functional Gastrointestinal Disorders. Front Pharmacol. 2020;11:596467 Authors: Melchior C, Desprez C, Wuestenberghs F, Leroi AM, Lemaire A, Goucerol G Abstract Objective: We aimed to determine the burden of opioid consumption in a cohort of patients with functional gastrointestinal disorders. Methods: All patients diagnosed with functional gastrointestinal disorders and referred to our university hospital were evaluated from 2013 to the beginning of 2019. Irritable bowel syndrome and functional dyspepsia diagnoses were determined
  27. It's important that all doctors have an understanding of #DGBI! https://twitter.com/KateScarlata_RD/status/1346439937307140096 (Feed generated with FetchRSS) View the full article
  28. Non-celiac wheat sensitivity: rationality and irrationality of a gluten-free diet in individuals affected with non-celiac disease: a review. BMC Gastroenterol. 2021 Jan 06;21(1):5 Authors: Sergi C, Villanacci V, Carroccio A Abstract Non-celiac gluten or wheat sensitivity (NCWS) is a "clinical entity induced by the ingestion of wheat leading to intestinal and/or extraintestinal symptoms that improve once the wheat-containing foodstuff is removed from the diet, and celiac disease and wheat allergy have been excluded". This mostly accepted definition raises several points that re
  1. Load more activity
Advertisement



×
×
  • Create New...